Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 27, 2023. (Total: 217315Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Carcinoma and WWOX[original query]
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.
International journal of cancer. Journal international du cancer 2011 Dec 129 (12): 2816-24.
Cancemi Lisa, Romei Cristina, Bertocchi Sara, Tarrini Giulia, Spitaleri Irene, Cipollini Monica, Landi Debora, Garritano Sonia, Pellegrini Giovanni, Cristaudo Alfonso, Pinchera Aldo, Barale Roberto, Elisei Rossella, Landi Stefano, Gemignani Federi
Decreased expression of WWOX in the development of esophageal squamous cell carcinoma.
Molecular carcinogenesis 2013 Apr 52 (4): 265-74.
Guo Wei, Wang Guiying, Dong Yuran, Guo Yanli, Kuang Gang, Dong Zhimi
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.
Asia-Pacific journal of clinical oncology 2017 Jul .
Lin Wey-Ran, Hsu Chao-Wei, Yeh Christopher Sung-Huan, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lin Chen-Chun, Chu Yu-De, Yeh Chau-Ti
Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
PloS one 2017 12 (4): e0176141.
Lee Hsiang-Lin, Cheng Hsin-Lin, Liu Yu-Fan, Chou Ming-Chih, Yang Shun-Fa, Chou Ying-E
Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.
Journal of Cancer 2018 9 (7): 1239-1247.
Chen Wanyong, Zhou Chenhao, Zhang Wentao, Atyah Manar, Yin Yirui, Guo Lei, Tang Weiguo, Dong Qiongzhu, Ye Qinghai, Ren Ni
Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival.
Urologic oncology 2019 Aug .
Hung Sheng-Chun, Chou Ying-Erh, Li Jian-Ri, Chen Chuan-Shu, Lin Chia-Yen, Chang Li-Wen, Chiu Kun-Yuan, Cheng Chen-Li, Ou Yen-Chuan, Wang Shian-Shiang, Yang Shun-
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.
The pharmacogenomics journal 2019 Oct .
Lin Chen-Chun, Hsu Chao-Wei, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lai Ming-Wei, Lin Chih-Lang, Chien Rong-Nan, Lin Kwang-Huei, Yeh Chau-Ti
Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.
PeerJ 2020 8 e9294.
Dutta Munmee, Nakagawa Hidewaki, Kato Hiroaki, Maejima Kazuhiro, Sasagawa Shota, Nakano Kaoru, Sasaki-Oku Aya, Fujimoto Akihiro, Mateos Raúl Nicolás, Patil Ashwini, Tanaka Hiroko, Miyano Satoru, Yasuda Takushi, Nakai Kenta, Fujita Masas
WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma.
Frontiers in oncology 2022 12 12 996820.
Chu Yu-De, Liu Hui-Fen, Chen Yi-Chen, Chou Chun-Hung, Yeh Chau-Ti
TOP